Subtype
Prostate Neoplasm
CI-CAN-00003778Explore in graph →
Non-malignant1,453 active trials24 approved drugs58 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003778Explore in graph →
Clinical trials
6,547 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05903781 | Value of Ultra-fast Prostate MRI in Prostate Cancer | completed | — | 536 | University of ZurichOTHER | 1 | May 14, 2025 | clinicaltrials |
| NCT02278185 | Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer | completed | Phase 2 | 19 | University of Colorado, DenverOTHER | 1 | May 11, 2025 | clinicaltrials |
| NCT04332744 | Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)(ZZ-First) | completed | Phase 2 | 54 | MedSIROTHER | 1 | May 11, 2025 | clinicaltrials |
| NCT03570619 | Immunotherapy in Patients With Metastatic Cancers and CDK12 Mutations(IMPACT) | completed | Phase 2 | 56 | University of Michigan Rogel Cancer CenterOTHER | 1 | May 8, 2025 | clinicaltrials |
| NCT04113811 | Microwave Needle Thermoablation for Treatment of Localized Prostate Cancer | completed | N/A | 30 | Chinese University of Hong KongOTHER | 1 | May 7, 2025 | clinicaltrials |
| NCT04685928 | Extended Systematic Versus Mri-Assisted pRostate Transperineal Biopsy(SMART) | completed | N/A | 403 | Chinese University of Hong KongOTHER | 1 | May 6, 2025 | clinicaltrials |
| NCT06500741 | Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients | completed | — | 374 | Astellas Pharma Global Development, Inc.INDUSTRY | 1 | May 6, 2025 | clinicaltrials |
| NCT01162135 | Digoxin for Recurrent Prostate Cancer | completed | Phase 2 | 16 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT01848067 | Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer | completed | Phase 1 / Phase 2 | 9 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 4, 2025 | clinicaltrials |
| NCT02603965 | Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery | completed | Phase 1 | 25 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT03013413 | Ultrasound-Based Imaging Using the Aixplorer System in Diagnosing Prostate Cancer in Patients Undergoing Biopsy | completed | N/A | 99 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | May 2, 2025 | clinicaltrials |
| NCT02339168 | Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer | completed | Phase 1 | 25 | University of California, DavisOTHER | 1 | May 1, 2025 | clinicaltrials |
| NCT02967458 | Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Study | completed | Phase 2 | 55 | Thomas Jefferson UniversityOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT06950996 | A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum | completed | — | 300 | Instituto de Investigacion Sanitaria La FeOTHER | 1 | Apr 30, 2025 | clinicaltrials |
| NCT02983279 | Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer | completed | N/A | 49 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT03076203 | Phase IB Trial of Radium-223 and Niraparib in Patients With Castrate Resistant Prostate Cancer (NiraRad) | completed | Phase 1 | 14 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Apr 29, 2025 | clinicaltrials |
| NCT02989623 | Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA | completed | N/A | 25 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityOTHER | 1 | Apr 24, 2025 | clinicaltrials |
| NCT00026754 | Eligibility Screening for the NIH Intramural Research Program Clinical Protocols | completed | — | 19,522 | National Cancer Institute (NCI)NIH | 1 | Apr 18, 2025 | clinicaltrials |
| NCT06237114 | Novel Robotic Prostatectomy Technique for Early Urinary Continence(TRS-RALP) | completed | — | 30 | Sir Mortimer B. Davis - Jewish General HospitalOTHER | 1 | Apr 18, 2025 | clinicaltrials |
| NCT03822845 | Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer | completed | Phase 2 / Phase 3 | 6 | Michael Graham PhD, MDOTHER | 1 | Apr 17, 2025 | clinicaltrials |
| NCT03936218 | Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer | completed | Phase 3 | 94 | Eurofarma Laboratorios S.A.INDUSTRY | 1 | Apr 17, 2025 | clinicaltrials |
| NCT02025010 | Study of Abiraterone Acetate Without Exogenous Glucocorticoids in Men With Castration-resistant Prostate Cancer | completed | Phase 2 | 60 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 15, 2025 | clinicaltrials |
| NCT06929065 | Randomized Trial of HIFU vs. Cryo for Prostate Cancer(KPFT) | completed | N/A | 50 | Kaiser PermanenteOTHER | 1 | Apr 15, 2025 | clinicaltrials |
| NCT01220869 | A Study of Degarelix in Taiwanese Patients With Prostate Cancer | completed | Phase 3 | 110 | Ferring PharmaceuticalsINDUSTRY | 1 | Apr 13, 2025 | clinicaltrials |
| NCT03261271 | Weight Management Aimed to Reduce Risk and Improve Outcomes From Radical Prostatectomy(WARRIOR) | completed | N/A | 40 | University of Kansas Medical CenterOTHER | 1 | Apr 13, 2025 | clinicaltrials |
| NCT02435472 | Active Surveillance Exercise Clinical Trial(ASX) | completed | N/A | 104 | University of California, San FranciscoOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT03661437 | Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy | completed | Early Phase 1 | 33 | City of Hope Medical CenterOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT06919159 | Intratumoral Heterogeneity on [18F]PSMA and [18F]FDG PET/CT in Predicting Invasion and Prognosis of Prostate Cancer | completed | — | 45 | Jiequn YuOTHER | 1 | Apr 11, 2025 | clinicaltrials |
| NCT03934606 | Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model | completed | — | 1,488 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Apr 10, 2025 | clinicaltrials |
| NCT05317143 | Evaluation of Prostate Cancer Margins | completed | — | 100 | Intuitive SurgicalINDUSTRY | 1 | Apr 9, 2025 | clinicaltrials |
| NCT02288247 | A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone(PRESIDE) | completed | Phase 3 | 688 | Astellas Pharma Europe Ltd.INDUSTRY | 16 | Apr 8, 2025 | clinicaltrials |
| NCT06482658 | Evaluation of Transrectal Perilesional Biopsy in Diagnosis of Prostate Cancer | completed | N/A | 380 | Peking University First HospitalOTHER | 1 | Apr 8, 2025 | clinicaltrials |
| NCT03768349 | PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer | completed | Early Phase 1 | 250 | Mayo ClinicOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT03654638 | Soy Bread Diet in Improving Immune Function in Participants With Prostate Cancer | completed | Phase 2 | 25 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 4, 2025 | clinicaltrials |
| NCT04925284 | Study of XB002 in Subjects With Solid Tumors (JEWEL-101) | completed | Phase 1 | 269 | ExelixisINDUSTRY | 9 | Apr 4, 2025 | clinicaltrials |
| NCT03668652 | Focal Prostate Ablation Versus Radical Prostatectomy(FARP) | completed | N/A | 213 | Oslo University HospitalOTHER | 1 | Apr 3, 2025 | clinicaltrials |
| NCT06377683 | Clinical Evaluation of 177Lu-DansyI-PSMA (LNC1011) in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 8 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Apr 1, 2025 | clinicaltrials |
| NCT04600336 | Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer | completed | Phase 2 | 88 | Alliance for Clinical Trials in OncologyOTHER | 1 | Mar 30, 2025 | clinicaltrials |
| NCT03093428 | Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC | completed | Phase 2 | 45 | Dana-Farber Cancer InstituteOTHER | 1 | Mar 28, 2025 | clinicaltrials |
| NCT03087903 | A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA | completed | N/A | 41 | University of Colorado, DenverOTHER | 1 | Mar 25, 2025 | clinicaltrials |
| NCT04049747 | Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer(IP4-CHRONOS) | completed | N/A | 100 | Imperial College LondonOTHER | 1 | Mar 24, 2025 | clinicaltrials |
| NCT05137067 | A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents. | completed | Phase 2 | 90 | Optimal Health ResearchOTHER | 1 | Mar 21, 2025 | clinicaltrials |
| NCT06883474 | Osteosclerotic Changes on CT Predict Survival in Prostate Cancer | completed | — | 211 | Sun Yat-sen UniversityOTHER | 0 | Mar 21, 2025 | clinicaltrials |
| NCT02420977 | Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer | completed | Early Phase 1 | 23 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT02649790 | Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications | completed | Phase 1 / Phase 2 | 277 | Karyopharm Therapeutics IncINDUSTRY | 5 | Mar 19, 2025 | clinicaltrials |
| NCT05910229 | Telephone Paramedical Support Prior to the Radiotherapy Simulation Scanner for Patients with Prostate Cancer(RTEPROST) | completed | N/A | 120 | Groupe Hospitalier de Bretagne SudOTHER | 1 | Mar 18, 2025 | clinicaltrials |
| NCT06559007 | Phase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male Participants | completed | Phase 1 | 24 | Atridia Pty Ltd.INDUSTRY | 1 | Mar 18, 2025 | clinicaltrials |
| NCT04318028 | An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate Cancer | completed | N/A | 20 | University of Southern CaliforniaOTHER | 1 | Mar 17, 2025 | clinicaltrials |
| NCT04832958 | Imaging Guided Surgery to Improve the Detection of Lymph Node Metastases in Prostate Cancer Patients | completed | Phase 2 | 81 | IRCCS San RaffaeleOTHER | 1 | Mar 14, 2025 | clinicaltrials |
| NCT05389202 | Study of Prostate Perfusion Before Embolization in Patients With Symptomatic Prostate Adenoma(EMBOPERF) | completed | N/A | 45 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Mar 10, 2025 | clinicaltrials |
Data updated 23 days agoSource updated May 14, 2025source: clinicaltrials